Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 16, 2018, Amyris, Inc. (the “Company”) appointed Anthony Hughes as its Chief Accounting Officer, reporting to the Company’s Chief Financial Officer.

Mr. Hughes, 53, has served as Senior Vice President, Chief Accounting Officer of ServiceSource International, Inc., a publicly-traded provider of outsourced, performance-based business solutions, since May 2015, and previously served as the Vice President, Corporate Controller of CRC Health Group, a provider of behavioral health care services, from January 2013 to May 2015. Mr. Hughes holds Bachelor of Science and Master of Science degrees in Accounting from the University of North Texas.

to an offer letter entered into between the Company and Mr. Hughes on May 16, 2018 (the “Offer Letter”), Mr. Hughes is expected to commence employment with the Company on June 4, 2018. The Offer Letter provides for an initial annual base salary for Mr. Hughes in the amount of $295,000. Mr. Hughes will also be eligible to receive an annual performance-based cash bonus, with an initial target bonus of $118,000, subject to the achievement of performance objectives. In connection with his appointment, the Company agreed to grant Mr. Hughes a stock option award and a restricted stock unit (“RSU”) award under the Company’s 2010 Equity Incentive Plan, consisting of: (i) a non-qualified stock option to purchase 24,375 shares of the Company’s common stock (vesting over four years, with 25% of the shares subject to the option vesting upon completion by Mr. Hughes of his twelfth month of employment with the Company and the remainder vesting over the following three years in 36 equal monthly installments) at an exercise price equal to the fair market value of the Company’s common stock on the date of grant; and (ii) an award of 55,875 RSUs, which would vest over three years in equal annual installments, in each case subject to continued service with the Company through the applicable vesting date.

Mr. Hughes will be eligible to participate in the Company’s compensation and benefits programs for employees on the same basis as other eligible employees, including health insurance; vacation, holidays and sick days; life insurance; disability insurance; and a Section 401(k) plan with an employer matching contribution.

About Amyris, Inc. (NASDAQ:AMRS)

Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.